Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis

Laurent Dubuquoy1, Emmelie A Jansson, Samir Deeb

  • 1Equipe Propre INSERM 0114 sur la Physiopathologie des Maladies Inflammatoires Intestinales, Lille, France.

Gastroenterology
|May 6, 2003
PubMed
Abstract

Insights

Intestinal bacteria influence PPAR gamma expression, which is reduced in ulcerative colitis patients. This finding highlights the role of gut microbiota in inflammatory bowel disease pathogenesis.

Area of Science:

  • Gastroenterology
  • Immunology
  • Microbiology

Background:

  • Peroxisome proliferator-activated receptor gamma (PPAR gamma) may inhibit colitis by reducing nuclear factor kappa B (NF-kappa B) activity.
  • Elevated NF-kappa B activators, such as toll-like receptor 4 (TLR4), are implicated in inflammatory bowel disease (IBD).

Purpose of the Study:

  • To investigate the influence of bacteria and their signaling pathways on PPAR gamma regulation in IBD.
  • To assess the role of TLR4 in PPAR gamma expression within the context of IBD.

Main Methods:

  • Assessed PPAR gamma expression in TLR4-transfected Caco-2 cells, germ-free mice, and TLR4-deficient mice (Lps(d)/Lps(d)).
  • Evaluated colonic PPAR gamma expression and gene polymorphisms in patients with Crohn's disease (CD) and ulcerative colitis (UC).

Main Results:

  • TLR4 signaling elevated PPAR gamma expression in a NF-kappa B-dependent manner.
  • Intestinal flora induced PPAR gamma expression in colonic epithelial cells of control mice.
  • UC patients showed significantly reduced colonic PPAR gamma expression compared to controls and CD patients, without gene mutations.

Conclusions:

  • Commensal intestinal flora significantly impacts PPAR gamma expression.
  • PPAR gamma expression is notably impaired in the colonic epithelial cells of ulcerative colitis patients.

Related Concept Videos

Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...